KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Eli Lilly (LLY) Net Margin (2016 - 2025)

Eli Lilly (LLY) has disclosed Net Margin for 16 consecutive years, with 34.41% as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Net Margin rose 182.0% year-over-year to 34.41%, compared with a TTM value of 31.67% through Dec 2025, up 816.0%, and an annual FY2025 reading of 31.67%, up 816.0% over the prior year.
  • Net Margin was 34.41% for Q4 2025 at Eli Lilly, up from 31.72% in the prior quarter.
  • Across five years, Net Margin topped out at 36.38% in Q2 2025 and bottomed at 0.6% in Q3 2023.
  • Average Net Margin over 5 years is 22.27%, with a median of 21.63% recorded in 2021.
  • The sharpest move saw Net Margin plummeted -2152bps in 2023, then soared 2323bps in 2025.
  • Year by year, Net Margin stood at 21.58% in 2021, then grew by 23bps to 26.54% in 2022, then fell by -12bps to 23.41% in 2023, then soared by 39bps to 32.59% in 2024, then rose by 6bps to 34.41% in 2025.
  • Business Quant data shows Net Margin for LLY at 34.41% in Q4 2025, 31.72% in Q3 2025, and 36.38% in Q2 2025.